Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
First author：Wang Yongjun
Corresponding author：Wang Yongjun
essential_information
- Person in charge：Wang Yongjun
- Data Sources： CHANCE
- Number of papers：OTHERS20190772
- Published time：2019-02-28
2019-02-28
Published articles
Journal：BMJ
Publication type: Research Article
IF(IF): 27.604
PMID: 30819687 Link To Pubmed Full text Download
Background And Purpose
Method
In patients with high risk, non-disabling ischaemic cerebrovascular events, including minor stroke and transient ischaemic attack, short term dual antiplatelet therapy should be given within 24 hours after the onset of symptoms and as early as possible
Conclusion
Further studies are needed to evaluate antiplatelet strategies, explore whether dual antiplatelet therapy could benefit broader patient population, and improve adherence of the recommended antiplatelet therapy